Complementary or alternative medicine as possible determinant of decreased persistence to aromatase inhibitor therapy among older women with non-metastatic breast cancer.
<h4>Purpose</h4>Aromatase inhibitor therapy (AI) significantly improves survival in breast cancer patients. Little is known about adherence and persistence to aromatase inhibitors and about the causes of treatment discontinuation among older women.<h4>Methods</h4>We constitut...
Guardado en:
Autores principales: | Laetitia Huiart, Anne-Deborah Bouhnik, Dominique Rey, Frédérique Rousseau, Frédérique Retornaz, Mégane Meresse, Marc Karim Bendiane, Patrice Viens, Roch Giorgi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c71efe80a1549d897d65ea0150e55b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effect Of Microgravity On Aromatase Expression In Sertoli Cells
por: Elisa Cirelli, et al.
Publicado: (2017) -
Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience
por: Li Y, et al.
Publicado: (2020) -
Interactions of aromatase and seladin-1: A neurosteroidogenic and gender perspective
por: Kelicen-Ugur Pelin, et al.
Publicado: (2019) -
Are another 5 years of adjuvant aromatase inhibitor therapy needed?
por: Mo QG, et al.
Publicado: (2016) -
Effect of aromatase inhibitors on sex differentiation and embryonic development in chicks
por: Salwan M. Abdulateef, et al.
Publicado: (2021)